Nova Patents
PL3789038T3

Humanized and chimeric monoclonal antibodies to cd47

Abstract

This record has no abstract on file.

Term

4.6 yearsto projected expiry

Projected expiry 13 May 2031, counted from filing; an application has no term until it is granted.

  1. Priority
  2. Filed
  3. Published
  4. Today
  5. Projected expiry

56 members in 14 offices

This recordMember, by publication datePriority claim4 more offices are in the list below

Priority claims1

Priority claims
DocumentOfficeKindDate
39565210United States of AmericaP

Members56

Family members, oldest first
DocumentOfficeKind
CA2797720A1CanadaA1
CA3138956A1CanadaA1
WO2011143624A2World Intellectual Property Organization (WIPO)A2
WO2011143624A3World Intellectual Property Organization (WIPO)A3
AU2011252851A1AustraliaA1
EP2569013A2European Patent Office (EPO)A2
US2013142786A1United States of AmericaA1
JP2013534409AJapanA
EP2569013A4European Patent Office (EPO)A4
US9017675B2United States of AmericaB2
US2015183874A1United States of AmericaA1
US9382320B2United States of AmericaB2
AU2011252851B2AustraliaB2
US2016304609A1United States of AmericaA1
EP2569013B1European Patent Office (EPO)B1
AU2016273893A1AustraliaA1
PT2569013TPortugalT
DK2569013T3DenmarkT3
JP2017039709AJapanA
HRP20170254T1CroatiaT1
ES2616010T3SpainT3
EP3181149A1European Patent Office (EPO)A1
JP6166177B2JapanB2
HUE031778T2HungaryT2
AU2018204448A1AustraliaA1
US2019112374A1United States of AmericaA1
JP2019216719AJapanA
AU2020203132A1AustraliaA1
EP3789038A1European Patent Office (EPO)A1
US2021087269A1United States of AmericaA1
US11014985B2United States of AmericaB2
US2021246206A1United States of AmericaA1
JP6943549B2JapanB2
JP6964631B2JapanB2
CA2797720CCanadaC
JP2022031635AJapanA
EP3789038B1European Patent Office (EPO)B1
DK3789038T3DenmarkT3
FI3789038T3FinlandT3
LT3789038TLithuaniaT
JP7199494B2JapanB2
PT3789038TPortugalT
PL3789038T3This recordPolandT3
AU2020203132B2AustraliaB2
HRP20221260T1CroatiaT1
ES2937174T3SpainT3
HUE060541T2HungaryT2
JP2023051986AJapanA
AU2023202660A1AustraliaA1
US11807684B2United States of AmericaB2
JP7412521B2JapanB2
US2024084006A1United States of AmericaA1
EP4349868A2European Patent Office (EPO)A2
JP2024050548AJapanA
EP4349868A3European Patent Office (EPO)A3
JP7763230B2JapanB2